Malvina Prapa

519 total citations
10 papers, 350 citations indexed

About

Malvina Prapa is a scholar working on Molecular Biology, Neurology and Oncology. According to data from OpenAlex, Malvina Prapa has authored 10 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Neurology and 4 papers in Oncology. Recurrent topics in Malvina Prapa's work include CAR-T cell therapy research (4 papers), Neuroblastoma Research and Treatments (4 papers) and Virus-based gene therapy research (3 papers). Malvina Prapa is often cited by papers focused on CAR-T cell therapy research (4 papers), Neuroblastoma Research and Treatments (4 papers) and Virus-based gene therapy research (3 papers). Malvina Prapa collaborates with scholars based in Italy, United States and Germany. Malvina Prapa's co-authors include Massimo Dominici, Carlotta Spano, Giulia Grisendi, Edwin M. Horwitz, Giulia Golinelli, Marco Bestagno, Tiziana Petrachi, Filippo Rossignoli, Giacomo Pavesi and Pierfranco Conté and has published in prestigious journals such as British Journal of Pharmacology, Stem Cells and Oncotarget.

In The Last Decade

Malvina Prapa

10 papers receiving 348 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Malvina Prapa Italy	7	198	139	87	83	76	10	350
Michael R. Weist United States	6	215 1.1×	95 0.7×	94 1.1×	123 1.5×	60 0.8×	8	352
Julien Fleurence France	7	217 1.1×	144 1.0×	140 1.6×	58 0.7×	34 0.4×	9	333
Cristina Corbetta Italy	6	150 0.8×	118 0.8×	128 1.5×	53 0.6×	144 1.9×	9	351
Haipeng Tao United States	5	350 1.8×	132 0.9×	193 2.2×	116 1.4×	76 1.0×	10	488
Monica Epstein United States	3	330 1.7×	72 0.5×	149 1.7×	131 1.6×	99 1.3×	5	395
Aesha Vakil United States	6	376 1.9×	129 0.9×	95 1.1×	77 0.9×	128 1.7×	16	478
Simon Khagi United States	9	113 0.6×	101 0.7×	67 0.8×	72 0.9×	110 1.4×	28	325
Déborah Meyran Australia	8	246 1.2×	184 1.3×	161 1.9×	61 0.7×	23 0.3×	16	419
Axel Hyrenius‐Wittsten Sweden	7	277 1.4×	249 1.8×	117 1.3×	124 1.5×	31 0.4×	11	621
Dana L. Schalk United States	13	294 1.5×	170 1.2×	214 2.5×	52 0.6×	19 0.3×	30	534

Countries citing papers authored by Malvina Prapa

Since Specialization

Citations

This map shows the geographic impact of Malvina Prapa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Malvina Prapa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Malvina Prapa more than expected).

Fields of papers citing papers by Malvina Prapa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Malvina Prapa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Malvina Prapa. The network helps show where Malvina Prapa may publish in the future.

Co-authorship network of co-authors of Malvina Prapa

This figure shows the co-authorship network connecting the top 25 collaborators of Malvina Prapa. A scholar is included among the top collaborators of Malvina Prapa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Malvina Prapa. Malvina Prapa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Dall’Ora, Massimiliano, Valentina Masciale, Malvina Prapa, et al.. (2023). Impact of soluble tumor necrosis factor-related apoptosis-inducing ligand released by engineered adipose mesenchymal stromal cells on white blood cells. Cytotherapy. 25(6). 605–614. 3 indexed citations

2.

Prapa, Malvina, Giulia Golinelli, Giulia Grisendi, et al.. (2021). GD2 CAR T cells against human glioblastoma. npj Precision Oncology. 5(1). 93–93. 59 indexed citations

3.

Golinelli, Giulia, Giulia Grisendi, Massimiliano Dall’Ora, et al.. (2021). Anti-GD2 CAR MSCs against metastatic Ewing's sarcoma. Translational Oncology. 15(1). 101240–101240. 17 indexed citations

4.

Ciccocioppo, Rachele, Patrizia Comoli, Giuseppe Astori, et al.. (2020). Developing cell therapies as drug products. British Journal of Pharmacology. 178(2). 262–279. 6 indexed citations

5.

Golinelli, Giulia, Giulia Grisendi, Malvina Prapa, et al.. (2018). Targeting GD2-positive glioblastoma by chimeric antigen receptor empowered mesenchymal progenitors. Cancer Gene Therapy. 27(7-8). 558–570. 83 indexed citations

6.

Orsi, Giulia, Monica Barbolini, Guido Ficarra, et al.. (2017). GD2 expression in breast cancer. Oncotarget. 8(19). 31592–31600. 42 indexed citations

7.

Spano, Carlotta, Giulia Grisendi, Olivia Candini, et al.. (2016). Soluble TRAIL-Armed Human AD-MSC as Novel Cell Therapy. Cytotherapy. 18(6). S24–S25. 1 indexed citations

8.

Grisendi, Giulia, Daniele Manganaro, Giuliano Montagnani, et al.. (2015). Detection of microparticles from human red blood cells by multiparametric flow cytometry.. IRIS UNIMORE (University of Modena and Reggio Emilia). 13(2). 274–80. 42 indexed citations

9.

Prapa, Malvina, Sara Caldrer, Carlotta Spano, et al.. (2015). A novel anti-GD2/4-1BB chimeric antigen receptor triggers neuroblastoma cell killing. Oncotarget. 6(28). 24884–24894. 54 indexed citations

10.

Grisendi, Giulia, Carlotta Spano, Valeria Rasini, et al.. (2014). Mesenchymal Progenitors ExpressingTRAILInduce Apoptosis in Sarcomas. Stem Cells. 33(3). 859–869. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact